CUREBEST Trademark

Trademark Overview


On Wednesday, April 14, 2021, a trademark application was filed for CUREBEST with the United States Patent and Trademark Office. The USPTO has given the CUREBEST trademark a serial number of 90645222. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, February 7, 2024. This trademark is owned by Sysmex Corporation. The CUREBEST trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing medical and scientific testing and research information in the field of genetics; Providing information regarding medical diagnostic testing results and disease conditions for medical diagnosis purposes; Providing medical diagnostic testing, monitoring, analysis, evaluation and reporting services, and information related thereto in the field of genetics; Providing medical diagnostic testing, monitoring, analysis, evaluation and reporting services, and information related thereto in the field of cancer diagnosis; Gene, protein and cell analysis for medical diagnostic testing purposes; Medical analyses, in particular gene, protein and cell analyses for diagnosing cancer and forecasting the expected progress of a cancerous illness; Clinical laboratory testing service for medical diagnostic purposes specifically for forecasting and predicting a recurrence of cancer; Medical services, in particular, laboratory testing services comprising the analysis of biological samples for medi...

Medical laboratory services, namely, clinical laboratory testing services and reporting of results for others for medical and scientific research purposes; Medical testing and research services in the field of genes, proteins and cells, and reporting of results for medical and scientific research purposes; Providing medical and scientific research information regarding diagnostic testing results and disease conditions; Providing laboratory research services in the field of gene expression; Gene expression analysis service for others in the nature of genetic testing for medical and scientific research purposes; Scientific research for medical purposes in the area of cancerous diseases; Medical research in the field of cancer diagnosis and cancer treatment; Providing medical and scientific research information in the field of forecasting and predicting a recurrence of cancer; Analytic and diagnostic testing services for medical and scientific research purposes, namely, the analysis of bi...
curebest

General Information


Serial Number90645222
Word MarkCUREBEST
Filing DateWednesday, April 14, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, February 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 22, 2022

Trademark Statements


Pseudo MarkCURE BEST
Goods and ServicesProviding medical and scientific testing and research information in the field of genetics; Providing information regarding medical diagnostic testing results and disease conditions for medical diagnosis purposes; Providing medical diagnostic testing, monitoring, analysis, evaluation and reporting services, and information related thereto in the field of genetics; Providing medical diagnostic testing, monitoring, analysis, evaluation and reporting services, and information related thereto in the field of cancer diagnosis; Gene, protein and cell analysis for medical diagnostic testing purposes; Medical analyses, in particular gene, protein and cell analyses for diagnosing cancer and forecasting the expected progress of a cancerous illness; Clinical laboratory testing service for medical diagnostic purposes specifically for forecasting and predicting a recurrence of cancer; Medical services, in particular, laboratory testing services comprising the analysis of biological samples for medical diagnostic purposes specifically for forecasting and predicting a recurrence of cancer
Goods and ServicesMedical laboratory services, namely, clinical laboratory testing services and reporting of results for others for medical and scientific research purposes; Medical testing and research services in the field of genes, proteins and cells, and reporting of results for medical and scientific research purposes; Providing medical and scientific research information regarding diagnostic testing results and disease conditions; Providing laboratory research services in the field of gene expression; Gene expression analysis service for others in the nature of genetic testing for medical and scientific research purposes; Scientific research for medical purposes in the area of cancerous diseases; Medical research in the field of cancer diagnosis and cancer treatment; Providing medical and scientific research information in the field of forecasting and predicting a recurrence of cancer; Analytic and diagnostic testing services for medical and scientific research purposes, namely, the analysis of biological samples for forecasting and predicting a recurrence of cancer

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 22, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 22, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSysmex Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKobe, Hyogo 651-0073
JP

Party NameSysmex Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKobe, Hyogo 651-0073
JP

Trademark Events


Event DateEvent Description
Friday, February 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 7, 2024SOU EXTENSION 4 GRANTED
Wednesday, February 7, 2024SOU EXTENSION 4 FILED
Wednesday, February 7, 2024SOU TEAS EXTENSION RECEIVED
Saturday, August 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 10, 2023SOU EXTENSION 3 GRANTED
Thursday, August 10, 2023SOU EXTENSION 3 FILED
Thursday, August 10, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, March 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 27, 2023SOU EXTENSION 2 GRANTED
Monday, February 27, 2023SOU EXTENSION 2 FILED
Monday, February 27, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 3, 2022SOU EXTENSION 1 GRANTED
Wednesday, August 3, 2022SOU EXTENSION 1 FILED
Wednesday, August 3, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, August 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 3, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, August 3, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, August 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 19, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 22, 2022PUBLISHED FOR OPPOSITION
Wednesday, February 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 23, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 22, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 13, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 13, 2021NON-FINAL ACTION E-MAILED
Wednesday, October 13, 2021NON-FINAL ACTION WRITTEN
Tuesday, October 5, 2021ASSIGNED TO EXAMINER
Thursday, July 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 12, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, July 12, 2021ASSIGNED TO LIE
Monday, June 28, 2021ASSIGNED TO LIE
Tuesday, April 20, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Saturday, April 17, 2021NEW APPLICATION ENTERED